QR Code

Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians

Rationale & Objective: Research in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) has focused on reducing treatment toxicities, notably through reduction of exposure to glucocorticoids. Glucocorticoid-sparing therapies such as avacopan are not widely available in many countries...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: David Massicotte-Azarniouch, Mark Canney, Priscilla Karnabi, Peter A. Merkel, Rachel B. Jones, Ruth J. Pepper, Alan D. Salama, Vimal K. Derebail, Nataliya Milman, Mats Junek, Christian Pagnoux, David R.W. Jayne, Michael Walsh
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2024-08-01
Rangatū:Kidney Medicine
Ngā marau:
Anti-neutrophil cytoplasmic antibody-associated vasculitis
cyclophosphamide
glucocorticoid
rituximab
survey
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S2590059524000694
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite